Cargando…
Undertreatment or Overtreatment With Statins: Where Are We?
Statins, in addition to healthy lifestyle interventions, are the cornerstone of lipid-lowering therapy. Other low-density lipoprotein (LDL)-lowering drugs include ezetimibe, bile acid sequestrants, and PCSK9 inhibitors. As new evidence emerges from new clinical trials, therapeutic goals change, lead...
Autores principales: | García-Fernández-Bravo, Irene, Torres-Do-Rego, Ana, López-Farré, Antonio, Galeano-Valle, Francisco, Demelo-Rodriguez, Pablo, Alvarez-Sala-Walther, Luis A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105719/ https://www.ncbi.nlm.nih.gov/pubmed/35571155 http://dx.doi.org/10.3389/fcvm.2022.808712 |
Ejemplares similares
-
Too much or too little medicine? Overdiagnosis, underdiagnosis, overtreatment and undertreatment in respiratory diseases
por: Dobler, Claudia C.
Publicado: (2019) -
Rivaroxaban for the treatment of venous thromboembolism in real life: A single-center prospective study
por: Demelo-Rodríguez, Pablo, et al.
Publicado: (2019) -
Widespread Misinterpretation of Advance Directives and Portable Orders for Life-Sustaining Treatments Threatens Patient Safety and Causes Undertreatment and Overtreatment
por: Mirarchi, Ferdinando, et al.
Publicado: (2023) -
Inflammatory Biomarkers in the Short-Term Prognosis of Venous Thromboembolism: A Narrative Review
por: Galeano-Valle, Francisco, et al.
Publicado: (2021) -
Undertreatment of Anticoagulant Therapy in Hospitalized Acute Ischemic Stroke Patients With Atrial Fibrillation
por: Gong, Xiaoxian, et al.
Publicado: (2022)